BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7
41 results:

  • 1. KMT2 Family of H3K4 Methyltransferases: Enzymatic Activity-dependent and -independent Functions.
    Van HT; Xie G; Dong P; Liu Z; Ge K
    J Mol Biol; 2024 Apr; 436(7):168453. PubMed ID: 38266981
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts.
    Agaimy A; Kasajima A; Stoehr R; Haller F; Schubart C; Tögel L; Pfarr N; von Werder A; Pavel ME; Sessa F; Uccella S; La Rosa S; Klöppel G
    Virchows Arch; 2023 Mar; 482(3):507-516. PubMed ID: 36690805
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Thioredoxin 1 (trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC.
    Ribback S; Winter S; Klatte T; Schaeffeler E; Gellert M; Stühler V; Scharpf M; Bedke J; Burchardt M; Schwab M; Lillig CH; Kroeger N
    World J Urol; 2022 Mar; 40(3):739-746. PubMed ID: 34859284
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Soft tissue perineurioma involving the kidney: a report of two cases with an emphasis on differential diagnosis.
    Ma TS; Zhou L; Zhou Q; He XL; Zhao M
    Diagn Pathol; 2021 Sep; 16(1):87. PubMed ID: 34592995
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Intrinsically Disordered Proteins mllT3 (AF9) and mllT1 (ENL) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, mll Fusion Leukemia, and kidney Cancer.
    Kabra A; Bushweller J
    J Mol Biol; 2022 Jan; 434(1):167117. PubMed ID: 34174329
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy.
    Sfakianos JP; Gul Z; Shariat SF; Matin SF; Daneshmand S; Plimack E; Lerner S; Roupret M; Pal S
    Eur Urol Oncol; 2021 Apr; 4(2):170-179. PubMed ID: 33386276
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia.
    Moskop A; Pommert L; Thakrar P; Talano J; Phelan R
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28739. PubMed ID: 33009894
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The first case of acute myeloid leukaemia/myeloid sarcoma with cytokeratin expression on blasts diagnosed on urine specimen.
    Comerford C; Ni Mhaolcatha S; Hayes B; Mykytiv V
    Hematol Oncol Stem Cell Ther; 2021 Dec; 14(4):343-347. PubMed ID: 32209310
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Bilateral Wilms tumors: Treatment results from a single center.
    Aydın B; Akyüz C; Yalçın B; Ekinci S; Oğuz B; Akçören Z; Yıldız F; Varan A; Kurucu N; Büyükpamukçu M; Kutluk T
    Turk J Pediatr; 2019; 61(1):44-51. PubMed ID: 31559721
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.
    Eich ML; Rodriguez Pena MDC; Springer SU; Taheri D; Tregnago AC; Salles DC; Bezerra SM; Cunha IW; Fujita K; Ertoy D; Bivalacqua TJ; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Netto GJ
    Mod Pathol; 2019 Oct; 32(10):1544-1550. PubMed ID: 31028363
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Magnetic resonance imaging characteristics and changes in hemostatic agents after partial nephrectomy.
    Kisa E; Sahin H; Cakmak O; Yucel C; Koc G; Kozacioglu Z; Ilbey YO
    Int Urol Nephrol; 2019 Jun; 51(6):917-925. PubMed ID: 30955139
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [
    Guo T; Dong X; Shi G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):551-555. PubMed ID: 30378308
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinicopathologic Features of a Series of Primary Renal CIC-rearranged Sarcomas With Comprehensive Molecular Analysis.
    Mangray S; Kelly DR; LeGuellec S; Fridman E; Aggarwal S; Shago M; Matoso A; Madison R; Pramanik S; Zhong S; Li R; Lombardo KA; Cramer S; Pressey J; Ross JS; Corona RJ; Bratslavsky G; Argani P; Coindre JM; Somers GR; Ali SM; Yakirevich E
    Am J Surg Pathol; 2018 Oct; 42(10):1360-1369. PubMed ID: 29901569
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Loss of BAP1 protein expression in the first metastatic site predicts prognosis in patients with clear cell renal cell carcinoma.
    Miura Y; Inoshita N; Ikeda M; Miyama Y; Oki R; Oka S; Kondoh C; Ozaki Y; Tanabe Y; Kurosawa K; Urakami S; Kohno T; Okaneya T; Takano T
    Urol Oncol; 2017 Jun; 35(6):386-391. PubMed ID: 28284891
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Survival analysis of surgically treated renal cell carcinoma: an analysis of 10-year data from single center].
    Zhang YS; Yu HY; Dong F; Li HZ
    Zhonghua Wai Ke Za Zhi; 2016 Jul; 54(7):528-33. PubMed ID: 27373480
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Real-World Axitinib Use in the United States: A Retrospective Study Using Linked Datasets.
    MacLean E; Cisar L; Mehle K; Eremina D; Quigley JM
    J Manag Care Spec Pharm; 2016 Jun; 22(6):723-732u. PubMed ID: 27231799
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.
    Wang J; Papanicolau-Sengos A; Chintala S; Wei L; Liu B; Hu Q; Miles KM; Conroy JM; Glenn ST; Costantini M; Magi-Galluzzi C; Signoretti S; Choueiri T; Gallucci M; Sentinelli S; Fazio VM; Poeta ML; Liu S; Morrison C; Pili R
    Oncotarget; 2016 May; 7(21):29901-15. PubMed ID: 27144525
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
    Park BJ; Cha MK; Kim IH
    BMC Res Notes; 2014 Jan; 7():7. PubMed ID: 24393391
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The mutational landscape of chromatin regulatory factors across 4,623 tumor samples.
    Gonzalez-Perez A; Jene-Sanz A; Lopez-Bigas N
    Genome Biol; 2013; 14(9):r106. PubMed ID: 24063517
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.